nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A New Therapeutic Era in the Management of Diabetic Kidney Disease
|
Rosas, Sylvia E. |
|
|
28 |
4 |
p. 280-281 |
artikel |
2 |
Editorial Board
|
|
|
|
28 |
4 |
p. A2 |
artikel |
3 |
Glucagon-Like Peptide-1 Receptor Agonists—Use in Clinical Practice
|
Tricò, Domenico |
|
|
28 |
4 |
p. 328-336 |
artikel |
4 |
Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes
|
Mosenzon, Ofri |
|
|
28 |
4 |
p. 347-360 |
artikel |
5 |
Masthead
|
|
|
|
28 |
4 |
p. A1 |
artikel |
6 |
Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists
|
Tommerdahl, Kalie L. |
|
|
28 |
4 |
p. 337-346 |
artikel |
7 |
Mineralocorticoid Receptor Antagonists—Evidence for Kidney Protection, Trials With Novel Agents
|
Al Dhaybi, Omar |
|
|
28 |
4 |
p. 371-377 |
artikel |
8 |
NKF 2022 Spring Clinical Meetings Physician Program
|
|
|
|
28 |
4 |
p. A8-A13 |
artikel |
9 |
Novel Anti-inflammatory and Anti-fibrotic Agents for Diabetic Kidney Disease—From Bench to Bedside
|
Nicholas, Susanne B. |
|
|
28 |
4 |
p. 378-390 |
artikel |
10 |
Novel Glucose-Lowering Therapies in the Setting of Solid Organ Transplantation
|
Nissaisorakarn, Pitchaphon |
|
|
28 |
4 |
p. 361-370 |
artikel |
11 |
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned
|
Neumiller, Joshua J. |
|
|
28 |
4 |
p. 318-327 |
artikel |
12 |
Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without Diabetes
|
Pollock, Carol |
|
|
28 |
4 |
p. 298-308 |
artikel |
13 |
Sodium-Glucose Transporter Inhibition in Adult and Pediatric Patients with Type 1 Diabetes Mellitus
|
Vitale, Rebecca J. |
|
|
28 |
4 |
p. 309-317 |
artikel |
14 |
Table of Contents
|
|
|
|
28 |
4 |
p. A4-A5 |
artikel |
15 |
Targeting the Pathobiology of Diabetic Kidney Disease
|
Thomas, Merlin C. |
|
|
28 |
4 |
p. 282-289 |
artikel |
16 |
Treatment of Diabetic Nephropathy: Changing Landscapes and New Horizons
|
Thakar, Charuhas V. |
|
|
28 |
4 |
p. 279 |
artikel |
17 |
What Have We Learned so Far From the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Clinical Practice?
|
Rossing, Peter |
|
|
28 |
4 |
p. 290-297 |
artikel |